Article Contents ::
- 1 The Brand Name MIGLIT-25 Has Generic Salt :: MIGLITOL
- 2 MIGLIT-25 Is From Company BIOCON LTD. Priced :: Rs. 60
- 3 MIGLIT-25 have MIGLITOL is comes under Sub class Insulin , Anti Diabetic drugs of Main Class Endocrine,Steroid Hormones , Metabolic System
- 4 Main Medicine Class:: Endocrine,Steroid Hormones , Metabolic System Sub Medicine Class :: Insulin , Anti Diabetic drugs
- 5 Disclaimer ::
- 6 The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
The Brand Name MIGLIT-25 Has Generic Salt :: MIGLITOL
MIGLIT-25 Is From Company BIOCON LTD. Priced :: Rs. 60
MIGLIT-25 have MIGLITOL is comes under Sub class Insulin , Anti Diabetic drugs of Main Class Endocrine,Steroid Hormones , Metabolic System
Main Medicine Class:: Endocrine,Steroid Hormones , Metabolic System Sub Medicine Class :: Insulin , Anti Diabetic drugs
| Salt Name : OR Generic Name | Form | Price : MRP /Probable | Packing | ||
| MIGLITOL | TAB | Rs. 60 | 10 |
| Brand Name | Company / Manufacturers | Strength | Unit | Price / 10 |
| MIGLIT-25 | BIOCON LTD. | 25MG | 10 | Rs. 60 |
| Company Brand Name | Salt Combination | Main Medical Class | Sub Medical Class |
| From BIOCON LTD. :: MIGLIT-25 | MIGLITOL | Endocrine,Steroid Hormones , Metabolic System | Insulin , Anti Diabetic drugs |
Indications for Drugs ::
Type 2 DM
Drug Dose ::
Adult: PO Initial:25 mg 3 times/day. May increase after 4-8 wk. Maintenance: 50 mg 3 times/day. Max:100 mg 3 times/day.
Contraindication ::
Renal clearance <25 ml/min, GI motility disorders or the presence of inflammatory bowel disease, diabetic ketoacidosis, colonic ulceration, or partial intestinal obstruction. Lactation. Drug Precautions ::
Hypoglycaemia, renal impairment.
Drug Side Effects ::
Abdominal pain, diarrhoea, flatulence, skin rash. To minimise GI effects, treatment may be initiated at 25 mg once daily and increased gradually to three times daily.
Pregnancy category ::
2
Drug Mode of Action ::
Miglitol reversibly inhibits membrane-bound intestinal ?-glucosidase enzymes which hydrolyse oligosaccharides and disaccharides to glucose and other monosaccharides in the small intestinal brush border. It delays carbohydrate breakdown, glucose absorption and reduces postprandial hyperglycaemia.
Drug Interactions ::
Concomitant use w/ insulin increases the risk of hypoglycaemia. Intestinal adsorbents (e.g. charcoal) and carbohydrate-splitting digestive enzyme supplements (e.g. amylase, pancreatin) may reduce glycaemic effects. May significantly reduce the bioavailability of ranitidine and propranolol.
